Vera Therapeutics (VERA) Institutional Ownership
13F filers reported holding 18.5% of Vera Therapeutics (VERA) shares as of Sep 30, 2026, across 91 filers.
- Held by 13F filers
- 18.5%
- Sep 30, 2026
- 13F filers
- 91
- quarter ended Sep 30, 2026
- 13F value
- $432.9M
- 13.4M shares
- Quarter's fund flow
- Mild accumulation
- 15 new · 10 closed
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Acquired · Option exercise | 5,000 | $3.94 | ↗ |
| Sep 11, 2026 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Disposed · Option exercise | 5,000Stock Option (right to buy) | — | ↗ |
| Sep 2, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Acquired · Option exercise | 18,500 | $2.90 | ↗ |
| Sep 2, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Disposed · Open-market sale | 18,500 | $35.12 | ↗ |
| Sep 2, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Disposed · Option exercise | 18,500Stock Option (Right to Buy) | — | ↗ |
| Aug 3, 2026 | Boman Nancy Lee | Chief Regulatory Officer | Acquired · Grant / award | 44,987 | — | ↗ |
| Aug 3, 2026 | Boman Nancy Lee | Chief Regulatory Officer | Acquired · Grant / award | 63,011Stock Option (right to buy) | — | ↗ |
| Jul 7, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Acquired · Option exercise | 46,250 | $2.90 | ↗ |
| Jul 7, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Disposed · Open-market sale | 1,000 | $40.78 | ↗ |
| Jul 7, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Disposed · Open-market sale | 32,550 | $42.07 | ↗ |
| Jul 7, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Disposed · Open-market sale | 10,500 | $42.86 | ↗ |
| Jul 7, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Disposed · Open-market sale | 2,200 | $43.59 | ↗ |
| Jul 7, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Disposed · Option exercise | 46,250Stock Option (Right to Buy) | — | ↗ |
| Jul 7, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Disposed · Open-market sale | 1,000 | $40.78 | ↗ |
| Jul 7, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Disposed · Open-market sale | 32,550 | $42.07 | ↗ |
| Jul 7, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Disposed · Open-market sale | 10,500 | $42.86 | ↗ |
| Jul 7, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Disposed · Open-market sale | 2,200 | $43.59 | ↗ |
| Jun 23, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Acquired · Option exercise | 18,500 | $2.90 | ↗ |
| Jun 23, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Disposed · Open-market sale | 18,412 | $37.93 | ↗ |
| Jun 23, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Disposed · Open-market sale | 88 | $38.43 | ↗ |
* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Vera Therapeutics do institutions hold?
13F filers reported holding 18.5% of Vera Therapeutics' shares as of Sep 30, 2026, across 91 filers.
How many 13F filers hold Vera Therapeutics?
Vera Therapeutics was held by 91 13F filers as of Sep 30, 2026.
Not investment advice.

